Celldex Therapeutics Competitors and Similar CompaniesClear all

Celldex Therapeutics's competitors and similar companies include Deciphera Pharmaceuticals and UCB.

	Celldex Therapeutics Celldex Therapeutics (formerly Avant Immunotherapeutics) is a biopharmaceutical company that specializes in monoclonal and bispecific antibodies development.	Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date	Founding Date 1983	Founding Date 2003	Founding Date 1928
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Hampton, US HQ Fall River, US Needham, US New Haven, US	Locations Waltham, US HQ Lawrence, US	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more
Employees	Employees 1608% increase	Employees 35037% increase	Employees 9,052
Valuation ($)	Valuation ($) 1.9 b	Valuation ($) 2.2 b	Valuation ($) 34.3 b
Financial
Revenue (est.)	Revenue (est.) $1.5m (FY, 2025)	Revenue (est.) $163.4m (FY, 2023)	Revenue (est.) €7.4b (FY, 2025)
Cost of goods	Cost of goods $200k (FY, 2025)	Cost of goods $3.7m (FY, 2023)	Cost of goods €1.4b (FY, 2025)
Gross profit	Gross profit $1.3m (FY, 2025)	Gross profit $159.6m (FY, 2023)	Gross profit €7.2b (FY, 2025)
Net income	Net income ($258.8m) (FY, 2025)	Net income ($194.9m) (FY, 2023)	Net income €1.6b (FY, 2025)
Funding
Total funding raised	Total funding raised $ 2m	Total funding raised $ 714m	Total funding raised N/A